205 related articles for article (PubMed ID: 34337953)
1. Renal Cell-Targeted Drug Delivery Strategy for Acute Kidney Injury and Chronic Kidney Disease: A Mini-Review.
Liu D; Du Y; Jin FY; Xu XL; Du YZ
Mol Pharm; 2021 Sep; 18(9):3206-3222. PubMed ID: 34337953
[TBL] [Abstract][Full Text] [Related]
2. Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression.
Gao L; Zhong X; Jin J; Li J; Meng XM
Signal Transduct Target Ther; 2020 Feb; 5(1):9. PubMed ID: 32296020
[TBL] [Abstract][Full Text] [Related]
3. Differential role of nicotinamide adenine dinucleotide deficiency in acute and chronic kidney disease.
Faivre A; Katsyuba E; Verissimo T; Lindenmeyer M; Rajaram RD; Naesens M; Heckenmeyer C; Mottis A; Feraille E; Cippà P; Cohen C; Longchamp A; Allagnat F; Rutkowski JM; Legouis D; Auwerx J; de Seigneux S
Nephrol Dial Transplant; 2021 Jan; 36(1):60-68. PubMed ID: 33099633
[TBL] [Abstract][Full Text] [Related]
4. A biomimetic double network hydrogel ameliorates renal fibrosis and promotes renal regeneration.
Zhang R; Hu Z; Wang Y; Qiu R; Wang G; Wang L; Hu B
J Mater Chem B; 2022 Nov; 10(45):9424-9437. PubMed ID: 36378134
[TBL] [Abstract][Full Text] [Related]
5. Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.
Hu MC; Shi M; Gillings N; Flores B; Takahashi M; Kuro-O M; Moe OW
Kidney Int; 2017 May; 91(5):1104-1114. PubMed ID: 28131398
[TBL] [Abstract][Full Text] [Related]
6. Delayed spironolactone administration prevents the transition from acute kidney injury to chronic kidney disease through improving renal inflammation.
Barrera-Chimal J; Rocha L; Amador-Martínez I; Pérez-Villalva R; González R; Cortés-González C; Uribe N; Ramírez V; Berman N; Gamba G; Bobadilla NA
Nephrol Dial Transplant; 2019 May; 34(5):794-801. PubMed ID: 30107561
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic Modification Drives Acute Kidney Injury-to-Chronic Kidney Disease Progression.
Li Z; Li N
Nephron; 2021; 145(6):737-747. PubMed ID: 34419948
[TBL] [Abstract][Full Text] [Related]
8. CSF-1R inhibition attenuates ischemia-induced renal injury and fibrosis by reducing Ly6C
Deng X; Yang Q; Wang Y; Zhou C; Guo Y; Hu Z; Liao W; Xu G; Zeng R
Int Immunopharmacol; 2020 Nov; 88():106854. PubMed ID: 32771945
[TBL] [Abstract][Full Text] [Related]
9. Targeting therapeutics to the glomerulus with nanoparticles.
Zuckerman JE; Davis ME
Adv Chronic Kidney Dis; 2013 Nov; 20(6):500-7. PubMed ID: 24206602
[TBL] [Abstract][Full Text] [Related]
10. Metformin: A Candidate Drug for Renal Diseases.
Corremans R; Vervaet BA; D'Haese PC; Neven E; Verhulst A
Int J Mol Sci; 2018 Dec; 20(1):. PubMed ID: 30583483
[TBL] [Abstract][Full Text] [Related]
11. An acute phase protein α
Watanabe H; Fujimura R; Hiramoto Y; Murata R; Nishida K; Bi J; Imafuku T; Komori H; Maeda H; Mukunoki A; Takeo T; Nakagata N; Tanaka M; Matsushita K; Fukagawa M; Maruyama T
Sci Rep; 2021 Apr; 11(1):7953. PubMed ID: 33846468
[TBL] [Abstract][Full Text] [Related]
12. The effects of acute renal failure on drug metabolism.
Philips BJ; Lane K; Dixon J; Macphee I
Expert Opin Drug Metab Toxicol; 2014 Jan; 10(1):11-23. PubMed ID: 24074057
[TBL] [Abstract][Full Text] [Related]
13. Insights into the Mechanisms of the Acute Kidney Injury-to-Chronic Kidney Disease Continuum.
Takaori K; Yanagita M
Nephron; 2016; 134(3):172-176. PubMed ID: 27398799
[TBL] [Abstract][Full Text] [Related]
14. Divergent effects of AKI to CKD models on inflammation and fibrosis.
Black LM; Lever JM; Traylor AM; Chen B; Yang Z; Esman SK; Jiang Y; Cutter GR; Boddu R; George JF; Agarwal A
Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1107-F1118. PubMed ID: 29897282
[TBL] [Abstract][Full Text] [Related]
15. Subcellular trafficking of tubular MDM2 implicates in acute kidney injury to chronic kidney disease transition during multiple low-dose cisplatin exposure.
Su H; Ye C; Lei CT; Tang H; Zeng JY; Yi F; Zhang C
FASEB J; 2020 Jan; 34(1):1620-1636. PubMed ID: 31914692
[TBL] [Abstract][Full Text] [Related]
16. Pediatric acute kidney injury and the subsequent risk for chronic kidney disease: is there cause for alarm?
Sigurjonsdottir VK; Chaturvedi S; Mammen C; Sutherland SM
Pediatr Nephrol; 2018 Nov; 33(11):2047-2055. PubMed ID: 29374316
[TBL] [Abstract][Full Text] [Related]
17. GSK3β-mediated Keap1-independent regulation of Nrf2 antioxidant response: A molecular rheostat of acute kidney injury to chronic kidney disease transition.
Lu M; Wang P; Qiao Y; Jiang C; Ge Y; Flickinger B; Malhotra DK; Dworkin LD; Liu Z; Gong R
Redox Biol; 2019 Sep; 26():101275. PubMed ID: 31349118
[TBL] [Abstract][Full Text] [Related]
18. Short-term dexamethasone treatment transiently, but not permanently, attenuates fibrosis after acute-to-chronic kidney injury.
Moonen L; Geryl H; D'Haese PC; Vervaet BA
BMC Nephrol; 2018 Dec; 19(1):343. PubMed ID: 30509215
[TBL] [Abstract][Full Text] [Related]
19. Enhanced efficiency of mitochondria-targeted peptide SS-31 for acute kidney injury by pH-responsive and AKI-kidney targeted nanopolyplexes.
Liu D; Jin F; Shu G; Xu X; Qi J; Kang X; Yu H; Lu K; Jiang S; Han F; You J; Du Y; Ji J
Biomaterials; 2019 Aug; 211():57-67. PubMed ID: 31085359
[TBL] [Abstract][Full Text] [Related]
20. Endoplasmic reticulum stress is activated in post-ischemic kidneys to promote chronic kidney disease.
Shu S; Zhu J; Liu Z; Tang C; Cai J; Dong Z
EBioMedicine; 2018 Nov; 37():269-280. PubMed ID: 30314894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
